Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

SELL
$5.37 - $8.35 $145,527 - $226,285
-27,100 Reduced 66.15%
13,868 $98,000
Q4 2023

Feb 14, 2024

SELL
$4.44 - $6.7 $63,936 - $96,480
-14,400 Reduced 26.01%
40,968 $274,000
Q3 2023

Nov 14, 2023

BUY
$5.23 - $9.24 $289,574 - $511,600
55,368 New
55,368 $311,000
Q1 2023

May 15, 2023

BUY
$4.71 - $6.66 $74,418 - $105,228
15,800 Added 29.08%
70,139 $438,000
Q4 2022

Feb 14, 2023

BUY
$4.06 - $5.71 $220,616 - $310,275
54,339 New
54,339 $253,000
Q3 2021

Nov 15, 2021

SELL
$29.63 - $46.98 $189,572 - $300,578
-6,398 Closed
0 $0
Q2 2021

Aug 13, 2021

BUY
$28.27 - $41.18 $180,871 - $263,469
6,398 New
6,398 $230,000

Others Institutions Holding GDRX

About GoodRx Holdings, Inc.


  • Ticker GDRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 84,394,800
  • Market Cap $360M
  • Description
  • GoodRx Holdings, Inc., through its subsidiaries, offers information and tools that enable consumers to compare prices and save on their prescription drug purchases in the United States. The company operates a price comparison platform that provides consumers with curated, geographically relevant prescription pricing, and access to negotiated pri...
More about GDRX
Track This Portfolio

Track Bayesian Capital Management, LP Portfolio

Follow Bayesian Capital Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bayesian Capital Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Bayesian Capital Management, LP with notifications on news.